Prophylactic tocilizumab before CD3/4-1bb anti-CD19 car-T cell infusion decreases incidence of severe crs without increased risk of neurotoxicity-MedSci.cn

Prophylactic tocilizumab before CD3/4-1bb anti-CD19 car-T cell infusion decreases incidence of severe crs without increased risk of neurotoxicity

Caimi, PF; Ahmed, N; Rojas, P; Andrade, L; Otegbeye, F; Patel, S; de Lima, M

CYTOTHERAPY, 2020; 22 (5): S16

科室
- - 订阅+
  - 更多科室
工具
服务